Pharma stocks face Q4 reality check amid global headwinds
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Analysts expect modest revenue growth but pressure on profitability in the March quarter
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
PMDA is regarded among the most stringent regulatory bodies globally
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Subscribe To Our Newsletter & Stay Updated